Senior Project Manager at Corcept Therapeutics

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s degree in a life science or related field or equivalent experience
At least 7 years relevant drug development experience in the pharmaceutical industry
At least 2 years cross-functional project management experience in the pharmaceutical industry
Demonstrated project management skills and experience supporting cross-functional drug development teams
Excellent interpersonal, analytical, creative problem-solving, and influence/negotiation skills
Knowledge of regulatory guidelines for drug development functions (ICH and FDA)
PMP or other Project Management certification/training preferred
Currently authorized to work in the United States on a full-time basis

Responsibilities

Under the guidance of Program Director(s), facilitate product development projects and programs including those involving pre-clinical and clinical research and development, commercialization, and product lifecycle management
Develop and keep up-to-date project plans and timelines
Anticipate issues and proactively mitigate risks and roadblocks
Manage meetings, including agenda preparation, meeting facilitation, documentation, and communication (e.g., distribution of minutes)
Drive project teams to achieve targets within appropriate quality standards, deadlines, budget, and resources
Drive project-level decision-making and facilitate resolution or escalation of issues
Ensure appropriate and effective communication within the project teams, senior management, and the program core teams
Provide formal and informal reports of project status to stakeholders
May take on additional responsibilities as delegated by the Program Directors
Support process initiatives and continuous improvement as needed

Skills

Project Management

Program Management

Clinical Development

Pre-Clinical Research

Risk Mitigation

Timeline Management

Stakeholder Management

Meeting Facilitation

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free